Venture Capital

Benchling Raises $200M Series E To Accelerate Biotech R&d

by prnewswire.com posted 5months ago 159 views
SAN FRANCISCO, April 14, 2021 /PRNewswire/ -- Benchling, the leading life sciences R&D cloud, has raised $200 million in Series E funding led by Sequoia Capital Global Equities and joined by Altimeter Capital, Byers Capital and Elad Gil. Existing investors participated, including Thrive...